Edition:
India

ARCA Biopharma Inc (ABIO.OQ)

ABIO.OQ on NASDAQ Stock Exchange Capital Market

1.33USD
12 Dec 2017
Change (% chg)

-- (--)
Prev Close
$1.33
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
17,189
52-wk High
$3.00
52-wk Low
$1.05

Latest Key Developments (Source: Significant Developments)

Arca Biopharma announces issuance of European patent on cardiovascular disease treatment methods
Thursday, 16 Nov 2017 

Nov 16 (Reuters) - Arca Biopharma Inc :Arca Biopharma announces issuance of European patent for treating cardiovascular diseases and conditions with a new chemical entity utilizing genetic targeting.Arca Biopharma- believes current cash, cash equivalents,marketable securities will be sufficient to fund its operations through end of Q2 of 2018​.  Full Article

ARCA Biopharma announces third quarter financial results
Friday, 10 Nov 2017 

Nov 9 (Reuters) - Arca Biopharma Inc :ARCA Biopharma announces third quarter 2017 financial results and provides business update.Q3 loss per share $0.39.ARCA Biopharma Inc - anticipate reporting top-line data for Genetic-AF clinical trial​ late in Q1 of 2018.ARCA Biopharma Inc - ‍expects research and development expenses in 2017 to be higher than 2016​.  Full Article

Arca Biopharma posts Q2 loss per share $0.43
Wednesday, 10 Aug 2016 

Arca Biopharma Inc : Arca Biopharma announces second quarter 2016 financial results and provides business update .Q2 loss per share $0.43.  Full Article

Arca Biopharma Q1 loss per share $0.40
Thursday, 12 May 2016 

Arca Biopharma Inc : Arca Biopharma Inc On Genetic-Af trial says expects outcome of interim analysis in Q2 of 2017. . Arca Biopharma announces first quarter 2016 financial results and provides business update .Q1 loss per share $0.40.  Full Article

BRIEF-Arca Biopharma announces issuance of European patent on cardiovascular disease treatment methods

* Arca Biopharma announces issuance of European patent for treating cardiovascular diseases and conditions with a new chemical entity utilizing genetic targeting